Activation of NF-κB signaling pathway in HSV-1-induced mouse facial palsy: Possible relation to therapeutic effect of glucocorticoids

Neuroscience. 2015 Mar 19:289:251-61. doi: 10.1016/j.neuroscience.2014.12.062. Epub 2015 Jan 13.

Abstract

It has been documented that infection of herpes simplex virus type 1 (HSV-1) contributes to the initiation of Bell's palsy. However, the exact mechanisms responsible for this disorder have not been fully elucidated to date. A mouse model of facial palsy induced by HSV-1 provides an opportunity to investigate the alteration in activities of nuclear factor-kappa B (NF-κB) and its consequent effect on two key inflammatory factors, i.e., tumor necrosis factor (TNF)-α and cyclooxygenase-2 (COX-2), as well as the effect of glucocorticoids (GCs) in this work. I-kappa B (IκB)-α phosphorylation and NF-κB nuclear translocation were measured by western blotting, and NF-κB/DNA binding activity was assessed by electrophoretic mobility shift assay (EMSA). Results showed the IκB-α phosphorylation and degradation as well as NF-κB activation in a time-dependent manner. The expression of TNF-α and COX-2 were determined by real-time polymerase chain reaction (PCR), western blotting and/or enzyme-linked immunosorbent assay (ELISA) respectively. Concomitant with the activation, the expression and secretion of TNF-α and COX-2 were rapidly induced in HSV-1-infected paralyzed mice. Conversely, the activation of NF-κB and up-regulation of TNF-α and COX-2 were blocked by pretreatment with NF-κB inhibitor pyrrolidine dithiocarbamate (PDTC) before being inoculated with HSV-1 to mice. In addition, GCs inhibited the nuclear translocation and DNA binding activity of NF-κB via inhibiting IκB-α degradation. Meanwhile, TNF-α production and COX-2 expression were significantly reduced by GCs. In conclusion, HSV-1 inoculation induced the activation of NF-κB, expression and secretion of TNF-α and COX-2 in the facial paralyzed mice, while, glucocorticoid effectively down-regulated TNF-α and COX-2 expression in HSV-1-induced paralyzed mice.

Keywords: cyclooxygenase-2; facial palsy; glucocorticoid; herpes simplex virus type 1; nuclear factor-kappa B; tumor necrosis factor-α.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus
  • Animals
  • Anti-Inflammatory Agents / administration & dosage*
  • Brain Stem / drug effects
  • Brain Stem / physiopathology*
  • Cyclooxygenase 2 / metabolism
  • Disease Models, Animal
  • Facial Paralysis / drug therapy*
  • Facial Paralysis / physiopathology*
  • Glucocorticoids / administration & dosage*
  • Herpesvirus 1, Human
  • Hormone Antagonists / pharmacology
  • I-kappa B Kinase / metabolism
  • Male
  • Methylprednisolone Hemisuccinate / administration & dosage
  • Mice, Inbred BALB C
  • Mifepristone / pharmacology
  • NF-kappa B / metabolism*
  • Pyrrolidines / pharmacology
  • Receptors, Glucocorticoid / antagonists & inhibitors
  • Receptors, Glucocorticoid / metabolism
  • Signal Transduction / drug effects
  • Thiocarbamates / pharmacology
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Anti-Inflammatory Agents
  • Glucocorticoids
  • Hormone Antagonists
  • NF-kappa B
  • Pyrrolidines
  • Receptors, Glucocorticoid
  • Thiocarbamates
  • Tumor Necrosis Factor-alpha
  • pyrrolidine dithiocarbamic acid
  • Mifepristone
  • Methylprednisolone Hemisuccinate
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Chuk protein, mouse
  • I-kappa B Kinase